Association of Medical Device Preprocessors Applauds FDA Extension


WASHINGTON, DC-The US Food and Drug Administration (FDA) has announced it will extend the application deadlines for premarket approval applications for certain reprocessed "single use" devices. The federal agency will also delay enforcement of the regulations affecting hospital reprocessors.

The Association of Medical Device Reprocessors (AMDR), a Washington, DC based trade association, represents the regulatory interest of third-party reprocessors of medical devices labeled for single use only. Pamela Furman, executive director of AMDR said the decision to postpone deadline date is the right decision, whether controversial or not.

"We applaud FDA for helping our nation's hospitals find ways to contain costs without jeopardizing the health and safety of patients," she said.

The controversy surrounds the Associations of Disposable Device Manufacturers (ADDM) disappointment in the deadline extension. ADDM officials said a recent death of a boy in the United Kingdom was related to medical equipment reprocessed incorrectly. They want the deadlines and enforcement to begin promptly.

The agency has released a statement saying officials will not begin regulating premarket requirements for ablation catheters until February, 14, 2002. This is the only action exception granted by FDA concerning active enforcement of premarket approval for all reprocessed Class III devices. Third-party reprocessing of Class II and Class I devices will be phased in during the next 12 months.

For the entire FDA statement, visit:

Information from the Association of Medical Device Reprocessors

Related Videos
Set of white bottles with cleaning liquids on the white background. (Adobe Stock 6338071172112 by zolnierek)
Medical investigators going over data. (AdobeStock 589197902 by Wasan)
CDC logo is seen on a laptop. (Adobe Stock 428450603 by monticellllo)
Association for the Health Care Environment (Logo used with permission)
COVID-19 germs, fungi, bacteria objects. (Adobe Stock 584704860 by chawalit)
Ambassador Deborah Birx, , speaks with Infection Control Today about masks in schools and the newest variant.
mRNA technology  (Adobe Stock 485886181 by kaptn)
Ambassador Deborah Birx, MD
Woman lying in hospital bed (Adobe Stock, unknown)
Related Content